ERBB2 and breast cancer: PC projections of the patient samples suggest that the extent of T cell-mediated cytotoxic immunity within invasive breast cancer is a continuous property, with TN breast cancer more prevalent at higher values for PC1 and HER2+ breast cancer more prevalent at lower values for PC1 (Figure S2C).